Industries > Pharma > Global Protein Expression Market Forecast to 2029

Global Protein Expression Market Forecast to 2029

Cell-free Expression System, Prokaryotic/Bacterial Expression System, Yeast Cell Expression Systems, Algal-based Expression Systems, Insect Cell Expression Systems, Mammalian Cell Expression Systems, Reagents, Expression Vectors, Competent Cells, Instruments, Services, Therapeutic Applications, Industrial Application, Research Application, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations (CROs)

PUBLISHED: 24 October 2019
PAGES: 201
PRODUCT CODE: PHA0553
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
SKU: PHA0553 Categories: , Tags: , , ,

The global protein expression market is estimated at $1.8bn in 2018. Visiongain estimated that the prokaryotic expression system accounted for 40.0% of the global protein expression market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 201-page report you will receive 70 tables and 115 figures– all unavailable elsewhere.

The 201-page report provides clear detailed insight into the global protein expression market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Protein Expression Market forecasts to 2029

• Global Protein Expression Market forecasts to 2029 by Expression System:
• Cell-free Expression System
• Prokaryotic/ Bacterial Expression System
• Yeast Cell Expression Systems
• Algal-based Expression Systems
• Insect Cell Expression Systems
• Mammalian Cell Expression Systems

Global Protein Expression Market Forecast to 2029

• Global Protein Expression Market forecasts to 2029 by Product & Services:
• Reagents
• Expression Vectors
• Competent Cells
• Instruments
• Services

• Global Protein Expression Market forecasts to 2029 by Application:
• Therapeutic Applications
• Industrial Application
• Research Application

• Global Protein Expression Market forecasts to 2029 by End-User:
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations (CROs)

• Global Protein Expression Market forecasts to 2029 by National Market:
• North America: US, Canada
• EU: Germany, France, UK, Italy, Spain
• Asia: Japan, China, India

• Assessment of selected leading companies that hold major market shares in the protein expression industry:
• Agilent Technologies
• Bio-Rad Technologies
• EMD Milipore
• New England Biolabs, Inc.
• Oxford Expression Technologies, Ltd.
• Promega Corporation
• Qiagen NV
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

• Discussions on trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT). It also analyses social, technological, economic and political factors (STEP) that influence the protein expression market. Moreover, this report discusses factors that drive and restrain the protein expression market.

• Key Questions Answered by This Report:
• What is the current size of the protein expression market? How much will this market be worth from 2019-2029?
• What will be the main drivers and restraints for this market?
• What are the different segments of the protein expression market? How much will each of these segments be worth during 2019-2029 and how will their market shares change during this period?
• What are the largest national protein expression markets? How much will these markets be worth from 2019-2029? How will the emerging markets affect the market shares of the mature markets?
• What are the most prominent companies in the market? What products and services do they offer, and what are the main features and advantages of them?
• What are the main trends affecting the market? What technologies will increase in prominence between 2019 and 2029? What are the advantages of these technologies?
• What are the main strengths, weaknesses, opportunities and threats for the market? What are the social, technological, economic and political factors affecting the market?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Protein Expression Market. You find data, trends and predictions.

Buy our report today Global Protein Expression Market analysis: Cell-free Expression System, Prokaryotic/Bacterial Expression System, Yeast Cell Expression Systems, Algal-based Expression Systems, Insect Cell Expression Systems, Mammalian Cell Expression Systems, Reagents, Expression Vectors, Competent Cells, Instruments, Services, Therapeutic Applications, Industrial Application, Research Application, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations (CROs)

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Protein Expression Market Forecast to 2029


Download sample pages

Complete the form below to download your free sample pages for Global Protein Expression Market Forecast to 2029


Latest Pharma news

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

READ

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

READ

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Categories

Category